Trastuzumab Withdrawn Phase 2 Trials for Neoplasms, Lung / Cancer, Breast / Lung Cancers / Neoplasms, Breast Diagnostic

IndicationsStatusPurposePhase
WithdrawnDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT01679743GRN1005 for Brain Metastases From Breast or Lung Cancer